Indegene, a digital life sciences marketing company, announces the opening of a new center in Germany, expanding its customer-focused consulting and management team in Frankfurt am Main. The company was supported by FrankfurtRheinMain GmbH International Marketing of the Region (FRM GmbH) in close coordination with Frankfurt Economic Development GmbH.
"When a company like Indegene decides to open its German headquarters in Frankfurt am Main in economically challenging times, it is a really positive signal. It shows once again that Frankfurt RheinMain is an absolutely competitive location internationally, whose strengths are appreciated by companies and investors alike," said Dr. Nargess Eskandari-Grünberg, acting mayor of the city of Frankfurt am Main.
Indegene Limited was founded in 1998 and is headquartered in Bengaluru, India. The company has been present in the European market for some time and has offices in the UK, Ireland and Switzerland. With this new office, Indegene continues to expand its presence in Europe to help life science companies accelerate digital transformation across the value chain. The local teams of experts will work closely with customers in Germany and Europe.
"Germany is a 'key market' for life sciences companies in Europe. The scale and pace of innovation, as well as the available talent skill set, is incredible," said Manish Gupta, Chairman and CEO of Indegene. "Our investment in Germany underscores our continued commitment to this region. With this new centralized structure, we can collaborate even more effectively with our customers and develop new digital innovations faster together."
Indegene has six operating centers and 16 offices in North America, Europe and Asia. According to the company, 19 of the top 20 biopharmaceutical companies, as well as numerous emerging biotech and medical device companies, are Indegene customers.
FRM GmbH accompanied the first steps of Indegene's settlement. The India team of the regional location marketing around Dr. Kasturi Dadhe supported the company in cooperation with the economic development of the city of Frankfurt in the search for suitable office space and the establishment of contacts with regional business networks.
"The location of Indegene Company's European headquarters shows that Frankfurt am Main is an attractive business location for the biotech industry as well. Frankfurt RheinMain is one of the locations worldwide where internationally active companies prefer to open their European headquarters. Thanks to its central location and an excellently developed infrastructure and existing industry clusters, our region offers these companies perfect conditions for working closely with their partners and suppliers and serving customers throughout Europe. The settlement is also proof of the success of close cooperation between the City of Frankfurt's Economic Development Department and the region's location marketing department," says Stephanie Wüst, City Councillor for Economic Affairs, Legal Affairs and Reforms of the City of Frankfurt am Main.